| 12419880 |
Companion diagnostic tool for mutant p53 reactivating compounds |
— |
2025-09-23 |
| 12023335 |
Method for treating pancreatic cancer |
Marla L. Weetall, Liangxian Cao, Thomas Davis, Jaime A. Eberle-Singh, Kenneth P. Olive |
2024-07-02 |
| 11938124 |
Combination therapy for treatment of cancer |
Arnold J. Levine |
2024-03-26 |
| 9402846 |
Combination of inhibitor of B-Raf and inhibitor of AKT in the treatment of cancer |
Tona Gilmer, Rakesh Kumar, Sylvie Laquerre, Peter F. Lebowitz, Shannon Renae Morris |
2016-08-02 |
| 8952018 |
Pharmaceutical combination of MEK inhibitor and B-Raf inhibitors |
Rakesh Kumar, Sylvie Laquerre, Peter F. Lebowitz |
2015-02-10 |
| 8835450 |
Combination of inhibitor of B-Raf and an inhibitor of Akt in the treatment of cancer |
Tona Gilmer, Rakesh Kumar, Peter F. Lebowitz, Shannon Renae Morris, Sylvie Laquerre |
2014-09-16 |
| 8796298 |
Combination of a B-Raf inhibitor: N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1- dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide and the Akt inhibitor: N-{ (1S)-2-amino-1-[(3- fluorophenyl)methyl]ethyl}-5-chIoro-4-(4-chIoro- 1 -methyl- 1 H-pyrazol-5-yl)-2-10 thiophenecarboxamide useful in the treatment of cancer |
Tona Gilmer, Rakesh Kumar, Peter F. Lebowitz, Shannon Renae Morris, Sylvie Laquerre |
2014-08-05 |
| 8703781 |
Pharmaceutical combination of MEK inhibitor and B-RAF inhibitors |
Rakesh Kumar, Sylvie Laquerre, Peter F. Lebowitz |
2014-04-22 |